Tranexamic acid in spontaneous intracerebral hemorrhage: an updated systematic review and meta-analysis of randomized controlled trials
In summary, TXA does not affect all-cause mortality, functional outcomes, or neurological impairment, nor does it reduce HE, despite reducing hematoma volulume. TXA use for ICH requires careful clinical consideration.
Authors
- Tao Ma
- LuDa Feng
- Cuilin Que
- Ying Gao
Institutions
- Beijing University of Chinese Medicine (CN)
- Chinese Institute for Brain Research (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1080/07853890.2026.2635208
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00